SurModics Inc (SRDX) - Net Assets

Latest as of June 2025: $111.31 Million USD

Based on the latest financial reports, SurModics Inc (SRDX) has net assets worth $111.31 Million USD as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($169.82 Million) and total liabilities ($58.51 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SRDX financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $111.31 Million
% of Total Assets 65.54%
Annual Growth Rate 6.58%
5-Year Change -9.28%
10-Year Change 27.34%
Growth Volatility 18.57

SurModics Inc - Net Assets Trend (1998–2024)

This chart illustrates how SurModics Inc's net assets have evolved over time, based on quarterly financial data. Also explore SRDX total asset value for the complete picture of this company's asset base.

Annual Net Assets for SurModics Inc (1998–2024)

The table below shows the annual net assets of SurModics Inc from 1998 to 2024. For live valuation and market cap data, see SurModics Inc (SRDX) market capitalisation.

Year Net Assets Change
2024-09-30 $118.90 Million -0.84%
2023-09-30 $119.91 Million +10.63%
2022-09-30 $108.39 Million -22.62%
2021-09-30 $140.09 Million +6.89%
2020-09-30 $131.06 Million +6.97%
2019-09-30 $122.52 Million +12.80%
2018-09-30 $108.61 Million -2.64%
2017-09-30 $111.56 Million +4.42%
2016-09-30 $106.83 Million +14.42%
2015-09-30 $93.37 Million -5.45%
2014-09-30 $98.75 Million +5.26%
2013-09-30 $93.82 Million -0.93%
2012-09-30 $94.69 Million -34.84%
2011-09-30 $145.34 Million -5.85%
2010-09-30 $154.36 Million -10.45%
2009-09-30 $172.37 Million +21.55%
2008-09-30 $141.81 Million +8.31%
2007-09-30 $130.92 Million -9.84%
2006-09-30 $145.20 Million +25.63%
2005-09-30 $115.58 Million +22.30%
2004-09-30 $94.50 Million +9.74%
2003-09-30 $86.11 Million +23.03%
2002-09-30 $70.00 Million +25.66%
2001-09-30 $55.70 Million +15.31%
2000-09-30 $48.30 Million +62.64%
1999-09-30 $29.70 Million +30.84%
1998-09-30 $22.70 Million --

Equity Component Analysis

This analysis shows how different components contribute to SurModics Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 8221300000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (September 2024)

Component Amount Percentage
Retained Earnings $75.71 Million 63.68%
Common Stock $716.00K 0.60%
Other Comprehensive Income $-2.13 Million -1.79%
Other Components $44.59 Million 37.51%
Total Equity $118.90 Million 100.00%

SurModics Inc Competitors by Market Cap

The table below lists competitors of SurModics Inc ranked by their market capitalization.

Company Market Cap
Shanghai Morn Electric Equipment Co Ltd
SHE:002451
 $614.53 Million
Cheng Loong Corp
TW:1904
 $614.53 Million
Hangzhou CNCR-IT Co Ltd
SHE:300250
 $614.62 Million
Jinlong Machinery Electronic
SHE:300032
 $614.68 Million
Changzhou Xiangming Intelligent Drive System Corporation
SHE:301226
 $614.39 Million
Guangdong Qunxing Toys Joint-Stock Co Ltd
SHE:002575
 $614.35 Million
MarineMax Inc
NYSE:HZO
 $614.34 Million
Haixia Envrnmnt
SHG:603817
 $613.98 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in SurModics Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 119,910,000 to 118,897,000, a change of -1,013,000 (-0.8%).
  • Net loss of 11,542,000 reduced equity.
  • New share issuances of 1,216,000 increased equity.
  • Other comprehensive income increased equity by 2,633,000.
  • Other factors increased equity by 6,680,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-11.54 Million -9.71%
Share Issuances $1.22 Million +1.02%
Other Comprehensive Income $2.63 Million +2.21%
Other Changes $6.68 Million +5.62%
Total Change $- -0.84%

Book Value vs Market Value Analysis

This analysis compares SurModics Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 5.12x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 25.74x to 5.12x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1998-09-30 $1.67 $42.98 x
1999-09-30 $1.88 $42.98 x
2000-09-30 $2.91 $42.98 x
2001-09-30 $3.12 $42.98 x
2002-09-30 $3.93 $42.98 x
2003-09-30 $4.83 $42.98 x
2004-09-30 $5.31 $42.98 x
2005-09-30 $6.37 $42.98 x
2006-09-30 $7.76 $42.98 x
2007-09-30 $7.19 $42.98 x
2008-09-30 $7.74 $42.98 x
2009-09-30 $9.87 $42.98 x
2010-09-30 $8.89 $42.98 x
2011-09-30 $8.32 $42.98 x
2012-09-30 $5.43 $42.98 x
2013-09-30 $6.37 $42.98 x
2014-09-30 $7.12 $42.98 x
2015-09-30 $7.03 $42.98 x
2016-09-30 $8.08 $42.98 x
2017-09-30 $8.33 $42.98 x
2018-09-30 $8.25 $42.98 x
2019-09-30 $8.89 $42.98 x
2020-09-30 $9.49 $42.98 x
2021-09-30 $10.01 $42.98 x
2022-09-30 $7.79 $42.98 x
2023-09-30 $8.55 $42.98 x
2024-09-30 $8.40 $42.98 x

Capital Efficiency Dashboard

This dashboard shows how efficiently SurModics Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -9.71%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -9.15%
  • • Asset Turnover: 0.71x
  • • Equity Multiplier: 1.50x
  • Recent ROE (-9.71%) is below the historical average (4.83%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1998 7.05% 16.33% 0.40x 1.07x $-670.00K
1999 14.81% 32.59% 0.42x 1.08x $1.43 Million
2000 8.78% 23.20% 0.36x 1.05x $-590.30K
2001 9.17% 22.51% 0.37x 1.09x $-461.00K
2002 11.14% 26.44% 0.38x 1.10x $796.50K
2003 16.18% 32.24% 0.44x 1.14x $5.32 Million
2004 7.87% 14.95% 0.45x 1.16x $-2.01 Million
2005 -7.13% -13.22% 0.50x 1.07x $-19.80 Million
2006 14.00% 29.10% 0.44x 1.08x $5.81 Million
2007 2.56% 4.57% 0.43x 1.31x $-9.75 Million
2008 10.39% 15.19% 0.51x 1.35x $558.40K
2009 21.78% 30.90% 0.65x 1.08x $20.31 Million
2010 -13.66% -30.17% 0.41x 1.10x $-36.52 Million
2011 -8.79% -18.85% 0.42x 1.12x $-27.31 Million
2012 10.80% 19.70% 0.50x 1.10x $761.50K
2013 16.17% 27.02% 0.55x 1.09x $5.79 Million
2014 12.18% 20.95% 0.55x 1.06x $2.16 Million
2015 14.40% 21.72% 0.62x 1.07x $4.11 Million
2016 9.35% 13.99% 0.54x 1.24x $-698.30K
2017 3.52% 5.37% 0.54x 1.22x $-7.23 Million
2018 -4.10% -5.48% 0.50x 1.51x $-15.32 Million
2019 6.20% 7.59% 0.63x 1.30x $-4.66 Million
2020 0.86% 1.18% 0.56x 1.29x $-11.98 Million
2021 3.02% 4.03% 0.54x 1.39x $-9.77 Million
2022 -25.16% -27.29% 0.63x 1.46x $-38.11 Million
2023 -1.28% -1.16% 0.71x 1.55x $-13.53 Million
2024 -9.71% -9.15% 0.71x 1.50x $-23.43 Million

Industry Comparison

This section compares SurModics Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $2,555,245,291
  • Average return on equity (ROE) among peers: -57.95%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
SurModics Inc (SRDX) $111.31 Million 7.05% 0.53x $614.51 Million
Abbott Laboratories (ABT) $24.08 Billion 18.37% 0.83x $155.56 Billion
Adagio Medical Holdings, Inc Common Stock (ADGM) $-95.88 Million 0.00% 0.00x $21.60 Million
Aethlon Medical Inc (AEMD) $9.29 Million -84.45% 0.15x $2.79 Million
Acutus Medical Inc (AFIB) $105.73 Million -116.68% 0.61x $903.35K
Adapthealth Corp (AHCO) $1.47 Billion -46.29% 2.07x $1.39 Billion
20/20 Biolabs, Inc. Common Stock (AIDX) $3.39 Million -59.65% 0.38x $15.99 Million
Allurion Technologies, Inc. (ALUR) $-70.49 Million 0.00% 0.00x $8.10 Million
Autonomix Medical, Inc. Common Stock (AMIX) $644.00K -309.01% 0.34x $4.22 Million
Artivion Inc (AORT) $30.20 Million 15.56% 0.78x $1.73 Billion
Apyx Medical Inc (APYX) $22.89 Million 2.69% 0.23x $125.55 Million

About SurModics Inc

NASDAQ:SRDX USA Medical Devices
Market Cap
$614.51 Million
Market Cap Rank
#11488 Global
#2763 in USA
Share Price
$42.98
Change (1 day)
+0.35%
52-Week Range
$26.42 - $42.98
All Time High
$80.35
Categories
Companies in USA Medical Devices
About

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision o… Read more